Genesis Research Group applies scientifically rigorous methodological and therapeutic expertise to maximize the value of real-world evidence (RWE) to decision-makers. Our RWE expertise includes: - Comparative effectiveness and safety studies - External control arms and label expansions - Drug utilization and treatment pattern analyses - Fit-for-purpose data assessments and data landscaping - Post-marketing requirements, commitments, and PASS - Targeted and systematic literature reviews, and meta-analyses - RWE regulatory strategy and global submission support. Genesis Research Group empowers life science companies to innovate differently by transforming the way they engage with research partners. We deliver impactful RWE, HEOR, and market access solutions that enable our partners to anticipate and address the evolving evidence needs of regulators and other stakeholders.
Genesis Research Group
111 River Street
Suite 1120
Hoboken, NJ 07030